Statistics for Aerovate Therapeutics, (id:6552 AVTE)

Valuation metrics

Market cap

76.81M

Enterprise value

-12,845,274.00

Trailing P/E (ttm)

-0.93

Forward P/E

-2.66

PEG ratio

-2.66

Price/Sales (ttm)

Price/Book (mrq)

0.95

Enterprise Value/Revenue

Enterprise Value/EBITDA

0.14

Overview

Shares outstanding

28.87M

Float

11.85M

Shares short

549.75K

% Held by insiders

0.00%

% Held by institutions

1.02%

Average volume (10 days)

308.29K

Average volume (90 days)

Price summary

52-Week low

1.25

52-Week high

32.42

52-Week change

-501.13%

Beta

1.00

50-Day moving average

2.27

200-Day moving average

11.11

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-48.67%

Return on equity

-82.06%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-89,957,000.00

Net income to common (ttm)

-84,611,000.00

Diluted EPS (ttm)

-2.99

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

88.73M

Total cash per share (mrq)

3.07

Total debt (mrq)

540.00K

Total Debt/Equity (mrq)

0.67

Current ratio (mrq)

878.40%

Book value per share (mrq)

2.79

Cash flow

Cash flow statement

-74,949,000.00

Levered free cash flow (LFCF)

-48,156,876.00